GB8510277D0 - Carbocyclic compounds - Google Patents

Carbocyclic compounds

Info

Publication number
GB8510277D0
GB8510277D0 GB858510277A GB8510277A GB8510277D0 GB 8510277 D0 GB8510277 D0 GB 8510277D0 GB 858510277 A GB858510277 A GB 858510277A GB 8510277 A GB8510277 A GB 8510277A GB 8510277 D0 GB8510277 D0 GB 8510277D0
Authority
GB
United Kingdom
Prior art keywords
carbocyclic compounds
carbocyclic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB858510277A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB858510277A priority Critical patent/GB8510277D0/en
Publication of GB8510277D0 publication Critical patent/GB8510277D0/en
Priority to IL78552A priority patent/IL78552A/en
Priority to LU86404A priority patent/LU86404A1/en
Priority to DE19863613573 priority patent/DE3613573A1/en
Priority to FR868605781A priority patent/FR2580632B1/en
Priority to NZ215910A priority patent/NZ215910A/en
Priority to AT0106986A priority patent/AT395421B/en
Priority to PT82440A priority patent/PT82440B/en
Priority to ZA863006A priority patent/ZA863006B/en
Priority to AU56461/86A priority patent/AU593797B2/en
Priority to CN86102778A priority patent/CN1011783B/en
Priority to KR1019860003086A priority patent/KR860008132A/en
Priority to GB08609821A priority patent/GB2174702B/en
Priority to CH1622/86A priority patent/CH667265A5/en
Priority to GR861060A priority patent/GR861060B/en
Priority to ES554238A priority patent/ES8802137A1/en
Priority to SE8601852A priority patent/SE460193B/en
Priority to BE0/216578A priority patent/BE904656A/en
Priority to FI861687A priority patent/FI85368C/en
Priority to NO861584A priority patent/NO165069C/en
Priority to DK183986A priority patent/DK183986A/en
Priority to CA000507274A priority patent/CA1275094A/en
Priority to PH33693A priority patent/PH23597A/en
Priority to NL8601025A priority patent/NL8601025A/en
Priority to IT47919/86A priority patent/IT1190277B/en
Priority to JP61092446A priority patent/JPS61249951A/en
Priority to HU864173A priority patent/HU199411B/en
Priority to MYPI86000259A priority patent/MY100829A/en
Priority to ES557659A priority patent/ES8900044A1/en
Priority to US07/097,334 priority patent/US4824993A/en
Priority to ES557828A priority patent/ES9000022A1/en
Priority to SG929/90A priority patent/SG92990G/en
Priority to HK516/91A priority patent/HK51691A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB858510277A 1984-04-23 1985-04-23 Carbocyclic compounds Pending GB8510277D0 (en)

Priority Applications (33)

Application Number Priority Date Filing Date Title
GB858510277A GB8510277D0 (en) 1985-04-23 1985-04-23 Carbocyclic compounds
IL78552A IL78552A (en) 1985-04-23 1986-04-21 Cyclopentyl ethers and their preparation and pharmaceutical formulation
IT47919/86A IT1190277B (en) 1985-04-23 1986-04-22 CYCLOPENTYL ETHERS THEIR PHARMACEUTICAL PREPARATION AND FORMULATION PROCESS CONTAINING THEM
SE8601852A SE460193B (en) 1985-04-23 1986-04-22 13-OXAPROSTAGLANDINES OF PGE TYPE, SET TO MANUFACTURING THESE AND A PHARMACEUTICAL COMPOSITION
BE0/216578A BE904656A (en) 1985-04-23 1986-04-22 CYCLOPENTYL ETHERS, THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM.
FR868605781A FR2580632B1 (en) 1985-04-23 1986-04-22 CYCLOPENTILIC ETHERS, THEIR PREPARATION AND PHARMACEUTICAL FORMULATION CONTAINING THEM
NZ215910A NZ215910A (en) 1985-04-23 1986-04-22 Cyclopentyl ethers and pharmaceutical compositions
AT0106986A AT395421B (en) 1985-04-23 1986-04-22 METHOD FOR PRODUCING NEW CYCLOPENTHYL ETHERS
PT82440A PT82440B (en) 1985-04-23 1986-04-22 PROCESS FOR THE PREPARATION OF CYCLOPENTILIC ETERS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ZA863006A ZA863006B (en) 1985-04-23 1986-04-22 Cyclopentyl ethers and their preparation and pharmaceutical formulation
AU56461/86A AU593797B2 (en) 1985-04-23 1986-04-22 Cyclopentyl ether and their preparation and pharmaceutical formulation
CN86102778A CN1011783B (en) 1985-04-23 1986-04-22 Process for preparation of cyclopentyl ethers
KR1019860003086A KR860008132A (en) 1985-04-23 1986-04-22 Process for preparing cyclopentyl ether
GB08609821A GB2174702B (en) 1985-04-23 1986-04-22 Cyclopentyl ethers and their preparation and pharmaceutical formulation
CH1622/86A CH667265A5 (en) 1985-04-23 1986-04-22 CYCLOPENTYL ETHER AND THEIR PRODUCTION AND PHARMACEUTICAL FORMULATION.
GR861060A GR861060B (en) 1985-04-23 1986-04-22 Cyclopentyl ethers and their preparation and pharmaceutical formulation
ES554238A ES8802137A1 (en) 1985-04-23 1986-04-22 Cyclopentyl ethes and their preparation and pharmaceutical formulation
LU86404A LU86404A1 (en) 1985-04-23 1986-04-22 CYCLOPENTYL ETHERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS
DE19863613573 DE3613573A1 (en) 1985-04-23 1986-04-22 CYCLOPENTYL ETHER AND THEIR PRODUCTION AND PHARMACEUTICAL FORMULATION
FI861687A FI85368C (en) 1985-04-23 1986-04-22 FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT ANVAENDBARA SYKLOPENTYLETRAR.
NO861584A NO165069C (en) 1985-04-23 1986-04-22 ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CYCLOPENTYLETERS.
DK183986A DK183986A (en) 1985-04-23 1986-04-22 CYCLOPENTYLETEETS, PROCEDURES FOR PREPARING THEM AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS
CA000507274A CA1275094A (en) 1985-04-23 1986-04-22 Cyclopentyl ethers and their preparation and pharmaceutical formulation
PH33693A PH23597A (en) 1985-04-23 1986-04-22 Phenyl and naphthyl esters of oxocyclopentyl ethers
NL8601025A NL8601025A (en) 1985-04-23 1986-04-22 CYCLOPENTYL ETHERS AND THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS.
JP61092446A JPS61249951A (en) 1985-04-23 1986-04-23 Cyclopentyl ethers, manufacture and medicinal composition
HU864173A HU199411B (en) 1985-04-23 1986-10-03 Process for producing cyclopentyl ether derivatives and pharmaceutical compositions containing them as active components
MYPI86000259A MY100829A (en) 1985-04-23 1986-12-30 Cyclopentyl ethers and their preparation and pharmaceutical formulation
ES557659A ES8900044A1 (en) 1985-04-23 1987-08-12 Cyclopentyl ethes and their preparation and pharmaceutical formulation
US07/097,334 US4824993A (en) 1984-04-23 1987-09-11 Cyclopentyl ethers and their preparation and pharmaceutical formulation
ES557828A ES9000022A1 (en) 1985-04-23 1988-04-12 Cyclopentyl ethes and their preparation and pharmaceutical formulation
SG929/90A SG92990G (en) 1985-04-23 1990-11-15 Cyclopentyl ethers and their preparation and pharmaceutical formulation
HK516/91A HK51691A (en) 1985-04-23 1991-07-04 Cyclopentyl ethers and their preparation and pharmaceutical formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858510277A GB8510277D0 (en) 1985-04-23 1985-04-23 Carbocyclic compounds

Publications (1)

Publication Number Publication Date
GB8510277D0 true GB8510277D0 (en) 1985-05-30

Family

ID=10578043

Family Applications (2)

Application Number Title Priority Date Filing Date
GB858510277A Pending GB8510277D0 (en) 1984-04-23 1985-04-23 Carbocyclic compounds
GB08609821A Expired GB2174702B (en) 1985-04-23 1986-04-22 Cyclopentyl ethers and their preparation and pharmaceutical formulation

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB08609821A Expired GB2174702B (en) 1985-04-23 1986-04-22 Cyclopentyl ethers and their preparation and pharmaceutical formulation

Country Status (29)

Country Link
JP (1) JPS61249951A (en)
KR (1) KR860008132A (en)
CN (1) CN1011783B (en)
AT (1) AT395421B (en)
AU (1) AU593797B2 (en)
BE (1) BE904656A (en)
CA (1) CA1275094A (en)
CH (1) CH667265A5 (en)
DE (1) DE3613573A1 (en)
DK (1) DK183986A (en)
ES (3) ES8802137A1 (en)
FI (1) FI85368C (en)
FR (1) FR2580632B1 (en)
GB (2) GB8510277D0 (en)
GR (1) GR861060B (en)
HK (1) HK51691A (en)
HU (1) HU199411B (en)
IL (1) IL78552A (en)
IT (1) IT1190277B (en)
LU (1) LU86404A1 (en)
MY (1) MY100829A (en)
NL (1) NL8601025A (en)
NO (1) NO165069C (en)
NZ (1) NZ215910A (en)
PH (1) PH23597A (en)
PT (1) PT82440B (en)
SE (1) SE460193B (en)
SG (1) SG92990G (en)
ZA (1) ZA863006B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8625322D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
EP0265247B1 (en) * 1986-10-22 1990-08-08 Glaxo Group Limited Cyclopentyl ethers and their preparation and pharmaceutical formulation
GB8625325D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
GB8625326D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Medicaments
GB8625321D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
JP2696933B2 (en) * 1987-06-16 1998-01-14 日産化学工業株式会社 Substituted cyclic ketones and substituted cyclic enones and methods for their preparation
US5227505A (en) * 1987-06-16 1993-07-13 Nissan Chemical Industries, Ltd. Substituted cyclic ketones, substituted cyclic enones, and process for producing the same
US5254708A (en) * 1987-06-16 1993-10-19 Nissan Chemical Industries, Ltd. Substituted cyclic ketones, substituted cyclic enones, and process for producing the same
US5231208A (en) * 1987-06-16 1993-07-27 Nissan Chemical Industries, Ltd. Substituted cyclic ketones, substituted cyclic enones, and process for producing the same
GB8822141D0 (en) * 1988-09-21 1988-10-26 Glaxo Group Ltd Chemical compounds
WO1999032441A1 (en) * 1997-12-22 1999-07-01 Alcon Laboratories, Inc. 13-oxa prostaglandins for the treatment of glaucoma and ocular hypertension
EP2422814A1 (en) 2003-07-25 2012-02-29 Ono Pharmaceutical Co., Ltd. Remedy for cartilage-related diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2082176B (en) * 1980-08-12 1984-07-11 Sanofi Sa Heteroprostaglandin derivatives and processes for preparing them
NZ197729A (en) * 1980-08-12 1985-03-20 Sanofi Sa 13-oxaprostanoic acid derivatives and pharmaceutical compositions
GB8410396D0 (en) * 1984-04-24 1984-05-31 Glaxo Group Ltd Carbocyclic compounds

Also Published As

Publication number Publication date
ES554238A0 (en) 1988-04-01
FR2580632B1 (en) 1989-09-15
NO861584L (en) 1986-10-24
FI85368B (en) 1991-12-31
GB2174702A (en) 1986-11-12
GR861060B (en) 1986-08-25
CN86102778A (en) 1986-10-22
CH667265A5 (en) 1988-09-30
HU199411B (en) 1990-02-28
SE8601852L (en) 1986-10-24
ATA106986A (en) 1992-05-15
GB2174702B (en) 1988-06-15
PT82440B (en) 1988-03-03
DK183986D0 (en) 1986-04-22
FI861687A0 (en) 1986-04-22
IT8647919A0 (en) 1986-04-22
BE904656A (en) 1986-10-22
PT82440A (en) 1986-05-01
NO165069B (en) 1990-09-10
DE3613573A1 (en) 1986-10-30
CA1275094A (en) 1990-10-09
SG92990G (en) 1991-01-18
IL78552A (en) 1989-12-15
ES9000022A1 (en) 1990-02-16
ES557659A0 (en) 1988-11-16
CN1011783B (en) 1991-02-27
FI85368C (en) 1992-04-10
SE460193B (en) 1989-09-18
HUT45010A (en) 1988-05-30
PH23597A (en) 1989-09-11
HK51691A (en) 1991-07-12
IL78552A0 (en) 1986-08-31
FR2580632A1 (en) 1986-10-24
AU5646186A (en) 1986-10-30
FI861687A (en) 1986-10-24
GB8609821D0 (en) 1986-05-29
NO165069C (en) 1990-12-19
AU593797B2 (en) 1990-02-22
MY100829A (en) 1991-03-15
LU86404A1 (en) 1986-11-05
ES557828A0 (en) 1990-02-16
NZ215910A (en) 1989-08-29
IT1190277B (en) 1988-02-16
KR860008132A (en) 1986-11-12
ES8802137A1 (en) 1988-04-01
DK183986A (en) 1986-10-24
JPS61249951A (en) 1986-11-07
AT395421B (en) 1992-12-28
ES8900044A1 (en) 1988-11-16
NL8601025A (en) 1986-11-17
ZA863006B (en) 1986-12-30
SE8601852D0 (en) 1986-04-22

Similar Documents

Publication Publication Date Title
GB8510758D0 (en) Compounds
GB8501999D0 (en) Compounds
GB8507942D0 (en) Compounds
GB8511988D0 (en) Compounds
GB8510277D0 (en) Carbocyclic compounds
GB2178740B (en) Alkylcarbamoyloxymethylcephem compounds
GB2203433B (en) Trizinyl compounds
EP0199465A3 (en) Cyanoalkanimidamido compounds
GB2169897B (en) 5- halopyridine-3-carboxamide compounds
GB2170200B (en) Acylaminoalkanoyl compounds
GB8510752D0 (en) Compounds
GB2183236B (en) Carbamoyloxymethylalkylcarbapenem compounds
GB8503358D0 (en) Compounds
GB2175586B (en) Mycotrienin-related compounds
GB8427129D0 (en) Carbocyclic compounds
GB8427128D0 (en) Carbocyclic compounds
GB8502690D0 (en) Compounds
GB8506642D0 (en) Compounds
GB8512142D0 (en) Compounds
GB8511759D0 (en) Compounds
GB8412774D0 (en) Carbocyclic compounds
GB8427130D0 (en) Carbocyclic compounds
GB8423083D0 (en) Carbocyclic compounds
GB8414676D0 (en) Carbocyclic compounds
GB8422455D0 (en) Carbocyclic compounds